Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.
Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.
复制标题
DOI:
10.1007/s00401-011-0860-9
复制
发表时间:
2011-10
影响因子:
12.7
通讯作者:
Hukema RK
中科院分区:
文献类型:
--
作者:
Hunsaker MR;Greco CM;Spath MA;Smits AP;Navarro CS;Tassone F;Kros JM;Severijnen LA;Berry-Kravis EM;Berman RF;Hagerman PJ;Willemsen R;Hagerman RJ;Hukema RK
Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder generally presenting with intention tremor and gait ataxia, but with a growing list of co-morbid medical conditions including hypothyroidism, hypertension, peripheral neuropathy, and cognitive decline. The pathological hallmark of FXTAS is the presence of intranuclear inclusions in both neurons and astroglia. However, it is unknown to what extent such inclusions are present outside the central nervous system (CNS). To address this issue, we surveyed non-CNS organs in ten human cases with FXTAS and in a CGG repeat knock-in (CGG KI) mouse model known to possess neuronal and astroglial inclusions. We find inclusions in multiple tissues from FXTAS cases and CGG KI mice, including pancreas, thyroid, adrenal gland, gastrointestinal, pituitary gland, pineal gland, heart, and mitral valve, as well as throughout the associated autonomic ganglia. Inclusions were observed in the testes, epididymis, and kidney of FXTAS cases, but were not observed in mice. These observations demonstrate extensive involvement of the peripheral nervous system and systemic organs. The finding of intranuclear inclusions in non-CNS somaticorgan systems, throughout the PNS, and in the enteric nervous system of both FXTAS cases as well as CGG KI mice suggests that these tissues may serve as potential sites to evaluate early intervention strategies or be used as diagnostic factors.
登录
查看更多内容
DOI:
10.4088/jcp.08m04476
发表时间:
2009-06
期刊:
The Journal of clinical psychiatry
影响因子:
--
作者:
Bourgeois JA;Coffey SM;Rivera SM;Hessl D;Gane LW;Tassone F;Greco C;Finucane B;Nelson L;Berry-Kravis E;Grigsby J;Hagerman PJ;Hagerman RJ
通讯作者:
Hagerman RJ
DOI:
10.2310/jim.0b013e3181af59d6
发表时间:
2009-12
期刊:
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
影响因子:
--
作者:
Berman RF;Willemsen R
通讯作者:
Willemsen R
影响因子:
2
作者:
Berry-Kravis, Elizabeth;Goetz, Christopher G.;Hagerman, Paul J.
通讯作者:
Hagerman, Paul J.
影响因子:
2.3
作者:
Gokden, Murat;Al-Hinti, Jomana T.;Harik, Sami I.
通讯作者:
Harik, Sami I.
DOI:
10.1002/ajmg.b.30910
发表时间:
2009-09-05
影响因子:
2.8
作者:
Brouwer, J. R.;Willemsen, R.;Oostra, B. A.
通讯作者:
Oostra, B. A.